Literature DB >> 28983918

How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013.

Louise F Wilson1, Annika Antonsson1,2, Adele C Green1,2,3, Susan J Jordan1,2, Bradley J Kendall1,2,4, Christina M Nagle1,2, Rachel E Neale1,2, Catherine M Olsen1,2, Penelope M Webb1,2, David C Whiteman1,2.   

Abstract

Cancer is a leading cause of disease burden in Australia, particularly fatal burden, accounting for an estimated thirty percent of deaths. Many cancers develop because of exposure to lifestyle and environmental factors that are potentially modifiable. We aimed to quantify the proportions and numbers of cancer deaths and cases in Australia in 2013 attributable to 20 modifiable factors in eight broad groupings that are established causes of cancer, namely: tobacco smoke (smoking and second-hand), dietary factors (low intake of fruit, non-starchy vegetables and dietary fibre; and high intake of red and processed meat), overweight/obesity, alcohol, physical inactivity, solar ultraviolet radiation, infections (seven agents), and reproductive factors (lack of breastfeeding, menopausal hormone therapy use, combined oral contraceptive use). We estimated population attributable fractions (PAF) using standard formulae incorporating exposure prevalence and relative risk data. Of all cancer deaths in Australia in 2013, approximately 38% overall (males 41%, females 34%) could be attributed to the factors assessed; the corresponding PAF for cancer cases was 33% (males 34%, females 32%). Tobacco smoke was the leading cause of cancer deaths and cases, with PAFs of 23 and 13%, respectively, followed by dietary factors (5% deaths/5% cases), overweight/obesity (5%/4%) and infections (5%/3%). Cancer sites with the highest numbers of potentially preventable deaths/cases were lung (n = 6,776/9,272), colorectum (n = 1,974/7,380) and cutaneous melanoma (n = 1,390/7,918). We estimate that about 16,700 cancer deaths and 41,200 cancer cases could be prevented in Australia each year if people's exposures to 20 causal factors were aligned with levels recommended to minimise cancer risk.
© 2017 UICC.

Entities:  

Keywords:  mortality; neoplasms; population attributable fraction; primary prevention; risk factors

Mesh:

Year:  2017        PMID: 28983918     DOI: 10.1002/ijc.31088

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.

Authors:  Dongfang Tang; Yu C Zhao; Hongliang Liu; Sheng Luo; Jeffrey M Clarke; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Wen Gao; Qingyi Wei
Journal:  Int J Cancer       Date:  2020-03-09       Impact factor: 7.396

2.  Cancers Due to Infection and Selected Environmental Factors.

Authors:  Thomas Gredner; Gundula Behrens; Christian Stock; Hermann Brenner; Ute Mons
Journal:  Dtsch Arztebl Int       Date:  2018-09-03       Impact factor: 5.594

3.  Dietary Drivers and Challenges of Australian Breast Cancer Survivors: A Qualitative Study.

Authors:  Daniel G Coro; Amanda D Hutchinson; Siobhan Banks; Alison M Coates
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-06-10

4.  Identifying causality, genetic correlation, priority and pathways of large-scale complex exposures of breast and ovarian cancers.

Authors:  Shucheng Si; Jiqing Li; Marlvin Anemey Tewara; Hongkai Li; Xinhui Liu; Yunxia Li; Xiaolu Chen; Congcong Liu; Tonghui Yuan; Wenchao Li; Bojie Wang; Fuzhong Xue
Journal:  Br J Cancer       Date:  2021-10-20       Impact factor: 9.075

Review 5.  Epigenetics/epigenomics of triterpenoids in cancer prevention and in health.

Authors:  Shanyi Li; Hsiao-Chen Dina Kuo; Ran Yin; Renyi Wu; Xia Liu; Lujing Wang; Rasika Hudlikar; Rebecca Mary Peter; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2020-02-29       Impact factor: 5.858

Review 6.  Cancer Prevention with Nutrition and Lifestyle.

Authors:  Eva Kerschbaum; Volkmar Nüssler
Journal:  Visc Med       Date:  2019-07-23

Review 7.  Anti-carcinogenic effects of exercise-conditioned human serum: evidence, relevance and opportunities.

Authors:  Richard S Metcalfe; Rachael Kemp; Shane M Heffernan; Rachel Churm; Yung-Chih Chen; José S Ruffino; Gillian E Conway; Giusy Tornillo; Samuel T Orange
Journal:  Eur J Appl Physiol       Date:  2021-04-17       Impact factor: 3.078

Review 8.  Metabolomics in cancer research and emerging applications in clinical oncology.

Authors:  Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale
Journal:  CA Cancer J Clin       Date:  2021-05-13       Impact factor: 286.130

9.  Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: A pooled analysis of data from two prospective cohort studies.

Authors:  Harindra Jayasekara; Robert J MacInnis; Leila Lujan-Barroso; Ana-Lucia Mayen-Chacon; Amanda J Cross; Bengt Wallner; Domenico Palli; Fulvio Ricceri; Valeria Pala; Salvatore Panico; Rosario Tumino; Tilman Kühn; Rudolf Kaaks; Kostas Tsilidis; Maria-Jose Sánchez; Pilar Amiano; Eva Ardanaz; María Dolores Chirlaque López; Susana Merino; Joseph A Rothwell; Marie-Christine Boutron-Ruault; Gianluca Severi; Hanna Sternby; Emily Sonestedt; Bas Bueno-de-Mesquita; Heiner Boeing; Ruth Travis; Torkjel M Sandanger; Antonia Trichopoulou; Anna Karakatsani; Eleni Peppa; Anne Tjønneland; Yi Yang; Allison M Hodge; Hazel Mitchell; Andrew Haydon; Robin Room; John L Hopper; Elisabete Weiderpass; Marc J Gunter; Elio Riboli; Graham G Giles; Roger L Milne; Antonio Agudo; Dallas R English; Pietro Ferrari
Journal:  Int J Cancer       Date:  2021-02-22       Impact factor: 7.316

10.  Healthy lifestyle and the risk of pancreatic cancer in the EPIC study.

Authors:  Sabine Naudin; Vivian Viallon; Dana Hashim; Heinz Freisling; Mazda Jenab; Elisabete Weiderpass; Flavie Perrier; Fiona McKenzie; H Bas Bueno-de-Mesquita; Anja Olsen; Anne Tjønneland; Christina C Dahm; Kim Overvad; Francesca R Mancini; Vinciane Rebours; Marie-Christine Boutron-Ruault; Verena Katzke; Rudolf Kaaks; Manuela Bergmann; Heiner Boeing; Eleni Peppa; Anna Karakatsani; Antonia Trichopoulou; Valeria Pala; Giovana Masala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Anne M May; Carla H van Gils; Charlotta Rylander; Kristin Benjaminsen Borch; María Dolores Chirlaque López; Maria-Jose Sánchez; Eva Ardanaz; José Ramón Quirós; Pilar Amiano Exezarreta; Malin Sund; Isabel Drake; Sara Regnér; Ruth C Travis; Nick Wareham; Dagfinn Aune; Elio Riboli; Marc J Gunter; Eric J Duell; Paul Brennan; Pietro Ferrari
Journal:  Eur J Epidemiol       Date:  2019-09-28       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.